2008 Reference Manual for Magnetic Resonance Imaging

Cardiotext Price: $70.00Availability: In stock. Usually ships within 24 hours. Rush shipping available.Product Information:
ISBN-13: 9780974641041
ISBN-10: 0974641049
Publisher: BRPG
Format: Paperback, 600 pages
Pub Date: 01/2008





Microsoft Smater EMR

Microsoft Envisions Smarter EMR Interfaces

Filed under: Informatics


Microsoft engineers are working on developing visual interfaces for electronic medical records (EMR), and have setup a website to help with brainstorming and demonstrating different ideas using Microsoft’s Common User Interface platform powered by Silverlight, the company’s high powered version of Adobe Flash.

From Microsoft Health’s Patient Journey Demonstrator:

The Patient Journey Demonstrator conceptualizes an end-to-end journey where a specific clinical scenario is used to illustrate how an integrated, patient-centric care record can transition seamlessly between care settings. It demonstrates how data can be accessed and entered from many of the care sources experienced along the patient journey.In this scenario, a man with suspected heart disease is examined by his family doctor. Using decision support tools, his doctor decides that the best course of action is to refer him for further tests. The scenario then tracks the activities that take place from the initial consultation through secondary care to an Angiogram.

Get Microsoft Silverlight

Silverlight 2.0 Beta 1 is required to run the Patient Journey Demonstrator. Please click on “Install Microsoft Silverlight”

Supported Operating Systems and Browsers

  • Windows Vista with Internet Explorer 7 and Firefox 1.5+
  • Windows XP SP2 with Internet Explorer 6+, and Firefox 1.5+
  • Windows Server 2003 (excluding IA-64) with Internet Explorer 6+, and Firefox 1.5+
  • Windows 2000 with Internet Explorer 6
  • Mac OS 10 4.8+ (Intel-based) with Firefox 1.5+ and Safari


Neuroarm does first surgery

I was wondering about this neuroarm after I wrote about it a while back. I am glad to see that they are getting some use out of all that technology. I would hate to see it go to waste. Here is some information about what Doctors in Canada are doing with this Robotic arm.

Surgeons at the Foothills Medical Centre in Canada performed the first procedure using the neuroArm microsurgery device, when they removed a tumor from the brain of a 21 year old woman.

We’ve reported about the neuroArm, a robot, developed at the University of Calgary, capable of operating inside an MRI machine’s magnetic field, in the past (see here, here, and here).

From a University of Calgary press release:

Paige Nickason, 21, is recovering after having a tumour removed from her brain with the assistance of neuroArm, a surgical robotic system developed by a team led by Dr. Garnette Sutherland, a Calgary Health Region neurosurgeon and professor of neurosurgery in the University of Calgary Faculty of Medicine.”I had to have the tumour removed anyway so I was happy to help by being a part of this historical surgery,” says Nickason, from her hospital room less than 24 hours after the surgery.

neuroArm is the world’s first MRI-compatible surgical robot capable of both microsurgery and image guided biopsy. The surgical robotic system is controlled by a surgeon from a computer workstation, working in conjunction with intraoperative MR (magnetic resonance) imaging. Dr. Sutherland developed the intraoperative MRI machine with Winnipeg-based IMRIS Inc. The technology allows a high field MRI scanner to move into the operating room on demand, providing imaging during the surgical procedure without compromising patient safety.

Aquilion one 3rd install Beth Israel Boston

“The Aquilion ONE has the potential to provide a single, comprehensive exam that can replace a variety of duplicative and invasive procedures,” added Dr. Raptopoulos. “Its versatility and ability to diagnose disease fast will be used within our radiology department to detect and treat life-threatening conditions, including cancer, heart disease, stroke and other neurovascular conditions.”


To get impressed, head on to the Aquilion ONE Clinical Movie Theatre at Toshiba, and check out some of the studies presented there…


Cardiac: Coronary artery bypass evaluation acquired using Aquilion ONE.

Chantix- Quit Smoking or Die trying

The Federal Aviation Administration (FAA) ruled on Wednesday that “Chantix was no longer acceptable for use by pilots and controllers,” FAA spokesperson Les Dorr tells WebMD. And the Federal Motor Carrier Safety Administration — the branch of the U.S. Department of Transportation that oversees trucking and busing — has told medical advisors that Chantix use could put the brakes on an interstate truck or bus driver’s medical fitness for duty.

The FDA has been analyzing reported adverse events — including suicidal thoughts and suicidal behavior — in Chantix users since late last year.

“In November, we had put on the [Chantix] label a precaution about use when operating heavy machinery,” Janet Woodcock, MD, director of the FDA’s Center for Drug Evaluation and Research, tells WebMD. 

The FAA knows of about 150 pilots and 30 air traffic controllers taking Chantix or have taken the drug in the past, notes Dorr, adding that the FAA told pilots and air traffic controllers to stop taking Chantix and to wait 72 hours before going back to work or flying.

In November 2007, the FDA announced that it was investigating reports of suicidal thinking, aggressive and erratic behavior, and drowsiness in people taking Chantix. At the time, the FDA advised patients to use caution when driving or operating machinery until they knew how Chantix may affect them. The FDA also stressed that it didn’t yet know if Chantix was responsible for those problems.

In February 2008, FDA officials noted that they have received nearly 500 reports of suicidal thoughts, behaviors, and completed suicides in people taking Chantix. Those reports don’t prove that Chantix was to blame for suicidal thinking, behaviors, or suicides. The FDA warned people taking Chantix that they might have trouble driving or operating heavy machinery.

Meanwhile, the FDA asks doctors and patients to report adverse events from Chantix — or any other drug — to the FDA’s MedWatch program.

This is shows how powerfull drug companies like Pfizer continue to turn a profit even at the sacrifice of others. Pfizer updated the Chantix web site with a “new safety information” link, dated May 2008, about reported mood changes, suicidal thoughts or behaviors, and cautions about driving or using heavy machinery. That information is already on the Chantix label.